{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:15:57Z","timestamp":1777486557920,"version":"3.51.4"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03285-3","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T22:33:40Z","timestamp":1764974020000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of Novel Drug Delivery Systems for Insulin Administration and Technological Advances in Diabetes Mellitus: Review"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6298-4992","authenticated-orcid":false,"given":"Hossamaldeen","family":"Bakrey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9893-1126","authenticated-orcid":false,"given":"Mazin Aboobaida Abdalla","family":"Abdelaziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0411-4120","authenticated-orcid":false,"given":"Fatehalrahman Faris","family":"Magbool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1617-4082","authenticated-orcid":false,"given":"Alaa","family":"Bakrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1620-7319","authenticated-orcid":false,"given":"Omer Ibrahim A.","family":"Omer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israa","family":"Abdelrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7617-7574","authenticated-orcid":false,"given":"Abdulkadir","family":"Abdu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"1","key":"3285_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.9734\/jpri\/2024\/v36i17493","volume":"36","author":"N Rais","year":"2024","unstructured":"Rais N, Ved A, Ahmad R, Parveen A. Oxidative stress and diabetes mellitus: unravelling the intricate connection: a comprehensive review. J Int Pharm Res. 2024;36(1):13\u201330. https:\/\/doi.org\/10.9734\/jpri\/2024\/v36i17493.","journal-title":"J Int Pharm Res"},{"key":"3285_CR2","doi-asserted-by":"publisher","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala A. A, Ogurtsova K, Shaw J E, Bright D. & Williams R.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice. 2019;157, 107843. https:\/\/doi.org\/10.1016\/j.diabres.2019.107843","DOI":"10.1016\/j.diabres.2019.107843"},{"key":"3285_CR3","doi-asserted-by":"publisher","unstructured":"Addendum. 10. Cardiovascular disease and risk management: standards of medical care in diabetes\u20142022. Diabetes Care. 2022;45(9):2178\u20132181. https:\/\/doi.org\/10.2337\/dc22-ad08.","DOI":"10.2337\/dc22-ad08"},{"key":"3285_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/409083","volume":"2013","author":"V Mohan","year":"2013","unstructured":"Mohan V, Seedat YK, Pradeepa R. The rising burden of diabetes and hypertension in Southeast Asian and African regions: need for effective strategies for prevention and control in primary health care settings. Int J Hypertens. 2013;2013: 409083. https:\/\/doi.org\/10.1155\/2013\/409083.","journal-title":"Int J Hypertens"},{"key":"3285_CR5","volume-title":"International textbook of diabetes mellitus","year":"2015","unstructured":"DeFronzo RA, Ferrannini E, Zimmet P, Alberti G, editors. International textbook of diabetes mellitus. 4th ed. Chichester: John Wiley & Sons; 2015.","edition":"4"},{"key":"3285_CR6","doi-asserted-by":"publisher","DOI":"10.3138\/9781487529147","volume-title":"The discovery of insulin","author":"M Bliss","year":"2021","unstructured":"Bliss M. The discovery of insulin. Toronto: University of Toronto Press; 2021."},{"issue":"2","key":"3285_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00253-004-1809-x","volume":"67","author":"G Walsh","year":"2004","unstructured":"Walsh G. Therapeutic insulins and their large-scale manufacture. Appl Microbiol Biotechnol. 2004;67(2):151\u20139. https:\/\/doi.org\/10.1007\/s00253-004-1809-x.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"2","key":"3285_CR8","doi-asserted-by":"publisher","DOI":"10.5799\/ahinjs.01.2016.02.0595","volume":"7","author":"E Yumusak","year":"2016","unstructured":"Yumusak E, K\u00fcc\u00fckevcilioglu M, Ornek K, B\u00fcy\u00fcktortop N. Effect of a single intravitreal ranibizumab injection on diabetic macular edema in patients who discontinued treatment. Int J Clin Exp Med. 2016;7(2): e595. https:\/\/doi.org\/10.5799\/ahinjs.01.2016.02.0595.","journal-title":"Int J Clin Exp Med"},{"issue":"9","key":"3285_CR9","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.molmet.2017.06.019","volume":"6","author":"C Chen","year":"2017","unstructured":"Chen C, Cohrs CM, Stertmann J, Bozsak R, Speier S. Human beta cell mass and function in diabetes: recent advances in knowledge and technologies to understand disease pathogenesis. Mol Metab. 2017;6(9):943\u201357. https:\/\/doi.org\/10.1016\/j.molmet.2017.06.019.","journal-title":"Mol Metab"},{"key":"3285_CR10","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.2147\/dddt.s79322","volume":"9","author":"E Matteucci","year":"2015","unstructured":"Matteucci E, Giampietro O, Covolan V, Giustarini D, Fanti P, Rossi R. Insulin administration: present strategies and future directions for a noninvasive (possibly more physiological) delivery. Drug Des Devel Ther. 2015;9:3109\u201318. https:\/\/doi.org\/10.2147\/dddt.s79322.","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"3285_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2174\/1381612825666190306153838","volume":"25","author":"BL Zaric","year":"2019","unstructured":"Zaric BL, Obradovic M, Sudar-Milovanovic E, Nedeljkovic J, Lazic V, Isenovic ER. Drug delivery systems for diabetes treatment. Curr Pharm Des. 2019;25(2):166\u201373. https:\/\/doi.org\/10.2174\/1381612825666190306153838.","journal-title":"Curr Pharm Des"},{"issue":"7","key":"3285_CR12","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3109\/1061186x.2013.805335","volume":"21","author":"H Li","year":"2013","unstructured":"Li H, Yu Y, Faraji Dana S, Li B, Lee CY, Kang L. Novel engineered systems for oral, mucosal and transdermal drug delivery. J Drug Target. 2013;21(7):611\u201329. https:\/\/doi.org\/10.3109\/1061186x.2013.805335.","journal-title":"J Drug Target"},{"issue":"6","key":"3285_CR13","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1210\/er.2018-00174","volume":"40","author":"R Lal","year":"2019","unstructured":"Lal R, Ekhlaspour L, Hood KK, Buckingham BA. Realizing a closed-loop (artificial pancreas) system for the treatment of type 1 diabetes. Endocr Rev. 2019;40(6):1521\u201343. https:\/\/doi.org\/10.1210\/er.2018-00174.","journal-title":"Endocr Rev"},{"issue":"15","key":"3285_CR14","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.addr.2007.08.019","volume":"59","author":"ES Khafagy","year":"2007","unstructured":"Khafagy ES, Morishita M, Onuki Y, Takayama K. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv Drug Deliv Rev. 2007;59(15):1521\u201346. https:\/\/doi.org\/10.1016\/j.addr.2007.08.019.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"3285_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11030664","volume":"11","author":"V Sugumar","year":"2023","unstructured":"Sugumar V, Hayyan M, Madhavan P, Wong WF, Looi CY. Current development of chemical penetration enhancers for transdermal insulin delivery. Biomedicines. 2023;11(3): 664. https:\/\/doi.org\/10.3390\/biomedicines11030664.","journal-title":"Biomedicines"},{"key":"3285_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1227423","volume":"14","author":"T Jamshidnejad-Tosaramandani","year":"2023","unstructured":"Jamshidnejad-Tosaramandani T, Kashanian S, Karimi I, Schi\u00f6th HB. Synthesis of an insulin-loaded mucoadhesive nanoparticle designed for intranasal administration: focus on new diffusion media. Front Pharmacol. 2023;14: 1227423. https:\/\/doi.org\/10.3389\/fphar.2023.1227423.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3285_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41574-023-00915-3","volume":"19","author":"S Starling","year":"2023","unstructured":"Starling S. Brain insulin action in women. Nat Rev Endocrinol. 2023;19(1):1. https:\/\/doi.org\/10.1038\/s41574-023-00915-3.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"3285_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrd4477","volume":"14","author":"O Veiseh","year":"2014","unstructured":"Veiseh O, Tang BC, Whitehead KA, Anderson DG, Langer R. Managing diabetes with nanomedicine: challenges and opportunities. Nat Rev Drug Discov. 2014;14(1):45\u201357. https:\/\/doi.org\/10.1038\/nrd4477.","journal-title":"Nat Rev Drug Discov"},{"key":"3285_CR19","doi-asserted-by":"publisher","first-page":"2306565","DOI":"10.1002\/smll.202306565","volume":"14","author":"ZM Zhuang","year":"2023","unstructured":"Zhuang ZM, Wang Y, Feng ZX, Lin XY, Wang ZC, Zhong XC, et al. Targeting diverse wounds and scars: recent innovative bio-design of microneedle patch for comprehensive management. Front Pharmacol. 2023;14:2306565. https:\/\/doi.org\/10.1002\/smll.202306565.","journal-title":"Front Pharmacol"},{"issue":"3","key":"3285_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/dia.2012.0331","volume":"15","author":"N Cohen","year":"2013","unstructured":"Cohen N, Hong ES, Van Drie C, Balkau B, Shaw JE. Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes. Diabetes Technol Ther. 2013;15(3):191\u20137. https:\/\/doi.org\/10.1089\/dia.2012.0331.","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"3285_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/jphp.12852","volume":"70","author":"A Gedawy","year":"2018","unstructured":"Gedawy A, Martinez J, Al-Salami H, Dass CR. Oral insulin delivery: existing barriers and current counter-strategies. J Pharm Pharmacol. 2018;70(2):197\u2013213. https:\/\/doi.org\/10.1111\/jphp.12852.","journal-title":"J Pharm Pharmacol"},{"issue":"Suppl 170","key":"3285_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1742-1241.2010.02577.x","volume":"65","author":"L Heinemann","year":"2011","unstructured":"Heinemann L. New ways of insulin delivery. Int J Clin Pract. 2011;65(Suppl 170):31\u201346. https:\/\/doi.org\/10.1111\/j.1742-1241.2010.02577.x.","journal-title":"Int J Clin Pract"},{"issue":"9","key":"3285_CR23","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1056\/nejm199602293340906","volume":"334","author":"CJ Bailey","year":"1996","unstructured":"Bailey CJ, Turner RC. Metformin. N Engl J Med. 1996;334(9):574\u20139. https:\/\/doi.org\/10.1056\/nejm199602293340906.","journal-title":"N Engl J Med"},{"issue":"1","key":"3285_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.56397\/ist.2024.01.04","volume":"3","author":"D Mohajan","year":"2024","unstructured":"Mohajan D, Mohajan HK. Oral hypoglycaemic agents: non-insulin medications for type 2 diabetes patients. Int J Innov Sci Technol. 2024;3(1):23\u201331. https:\/\/doi.org\/10.56397\/ist.2024.01.04.","journal-title":"Int J Innov Sci Technol"},{"key":"3285_CR25","doi-asserted-by":"publisher","unstructured":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837\u2013853. https:\/\/doi.org\/10.1016\/s0140-6736(98)07019-6\n.","DOI":"10.1016\/s0140-6736(98)07019-6"},{"issue":"12","key":"3285_CR26","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.2337\/dci18-0033","volume":"41","author":"MJ Davies","year":"2018","unstructured":"Davies MJ, D\u2019Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, et al. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018;41(12):2669\u2013701. https:\/\/doi.org\/10.2337\/dci18-0033.","journal-title":"Diabetes Care"},{"issue":"11","key":"3285_CR27","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.2337\/diacare.28.11.2673","volume":"28","author":"M Peyrot","year":"2005","unstructured":"Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, et al. Resistance to insulin therapy among patients and providers. Diabetes Care. 2005;28(11):2673\u20139. https:\/\/doi.org\/10.2337\/diacare.28.11.2673.","journal-title":"Diabetes Care"},{"issue":"2","key":"3285_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/j.1875-9114.1985.tb03404.x","volume":"5","author":"JM Feldman","year":"1985","unstructured":"Feldman JM. Glyburide: a second-generation sulfonylurea hypoglycemic agent. Pharmacotherapy. 1985;5(2):43\u201362. https:\/\/doi.org\/10.1002\/j.1875-9114.1985.tb03404.x.","journal-title":"Pharmacotherapy"},{"issue":"3","key":"3285_CR29","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/14656566.2021.1999413","volume":"23","author":"B Tomlinson","year":"2021","unstructured":"Tomlinson B, Patil NG, Fok M, Chan P, Lam CWK. The role of sulfonylureas in the treatment of type 2 diabetes. Expert Opin Pharmacother. 2021;23(3):387\u2013403. https:\/\/doi.org\/10.1080\/14656566.2021.1999413.","journal-title":"Expert Opin Pharmacother"},{"issue":"12","key":"3285_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11892-019-1270-y","volume":"19","author":"HE Lebovitz","year":"2019","unstructured":"Lebovitz HE. Thiazolidinediones: the forgotten diabetes medications. Curr Diab Rep. 2019;19(12):161. https:\/\/doi.org\/10.1007\/s11892-019-1270-y.","journal-title":"Curr Diab Rep"},{"key":"3285_CR31","doi-asserted-by":"publisher","unstructured":"Richter B, Bandeira-Echtler E, Bergerhoff K, Lerch C. Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010;(1):CD006739.  https:\/\/doi.org\/10.1002\/14651858.cd006739.pub2.","DOI":"10.1002\/14651858.cd006739.pub2"},{"issue":"9","key":"3285_CR32","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1111\/dom.14773","volume":"24","author":"T Heise","year":"2022","unstructured":"Heise T, Piras de Oliveira C, Juneja R, Ribeiro A, Chigutsa F, Blevins T. What is the value of faster acting prandial insulin? Focus on ultra rapid lispro. Diabetes Obes Metab. 2022;24(9):1689\u2013701. https:\/\/doi.org\/10.1111\/dom.14773.","journal-title":"Diabetes Obes Metab."},{"issue":"1","key":"3285_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/dom.12178","volume":"16","author":"G Koehler","year":"2013","unstructured":"Koehler G, Treiber G, Wutte A, Korsatko S, Mader JK, Semlitsch B, et al. Pharmacodynamics of the long-acting insulin analogues detemir and glargine following single-doses and under steady-state conditions in patients with type 1 diabetes. Diabetes Obes Metab. 2013;16(1):57\u201362. https:\/\/doi.org\/10.1111\/dom.12178.","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"3285_CR34","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s13300-020-00831-z","volume":"11","author":"J Kesavadev","year":"2020","unstructured":"Kesavadev J, Saboo B, Krishna MB, Krishnan G. Evolution of insulin delivery devices: from syringes, pens and pumps to DIY artificial pancreas. Diabetes Ther. 2020;11(6):1251\u201369. https:\/\/doi.org\/10.1007\/s13300-020-00831-z.","journal-title":"Diabetes Ther"},{"issue":"5","key":"3285_CR35","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1177\/1932296815581052","volume":"9","author":"RR Gehlaut","year":"2015","unstructured":"Gehlaut RR, Dogbey GY, Schwartz FL, Marling CR, Shubrook JH. Hypoglycemia in type 2 diabetes - more common than you think. J Diabetes Sci Technol. 2015;9(5):999\u20131005. https:\/\/doi.org\/10.1177\/1932296815581052.","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"3285_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrendo.2014.203","volume":"11","author":"RIG Holt","year":"2014","unstructured":"Holt RIG, Mitchell AJ. Diabetes mellitus and severe mental illness: mechanisms and clinical implications. Nat Rev Endocrinol. 2014;11(2):79\u201389. https:\/\/doi.org\/10.1038\/nrendo.2014.203.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"3285_CR37","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/jama.287.3.360","volume":"287","author":"SE Inzucchi","year":"2002","unstructured":"Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes. JAMA. 2002;287(3):360\u201372. https:\/\/doi.org\/10.1001\/jama.287.3.360.","journal-title":"JAMA"},{"issue":"4","key":"3285_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.11648\/j.ijde.20190404.14","volume":"4","author":"BA Ademolu","year":"2019","unstructured":"Ademolu BA. Sulfonylureas induced hypoglycemia in diabetics - a review. Int J Diabetes Endocrinol. 2019;4(4):108\u201311. https:\/\/doi.org\/10.11648\/j.ijde.20190404.14.","journal-title":"Int J Diabetes Endocrinol"},{"issue":"9","key":"3285_CR39","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2146\/ajhp060446","volume":"64","author":"MC Granberry","year":"2007","unstructured":"Granberry MC, Hawkins JB, Franks AM. Thiazolidinediones in patients with type 2 diabetes mellitus and heart failure. Am J Health-Syst Pharm. 2007;64(9):931\u20136. https:\/\/doi.org\/10.2146\/ajhp060446.","journal-title":"Am J Health-Syst Pharm"},{"issue":"6","key":"3285_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.22270\/ujpr.v3i6.221","volume":"3","author":"P Mathur","year":"2019","unstructured":"Mathur P, Mathur CK, Mathur K. Oral drug delivery of insulin in diabetes mellitus: an attractive alternate to overcome invasive route. Univ J Pharm Res. 2019;3(6):47\u20139. https:\/\/doi.org\/10.22270\/ujpr.v3i6.221.","journal-title":"Univ J Pharm Res"},{"key":"3285_CR41","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2147\/jmdh.s64084","volume":"7","author":"C Sorli","year":"2014","unstructured":"Sorli C, Heile MK. Identifying and meeting the challenges of insulin therapy in type 2 diabetes. J Multidiscip Healthc. 2014;7:267\u201382. https:\/\/doi.org\/10.2147\/jmdh.s64084.","journal-title":"J Multidiscip Healthc"},{"issue":"S3","key":"3285_CR42","doi-asserted-by":"publisher","first-page":"S-25","DOI":"10.1089\/dia.2017.0035","volume":"19","author":"D Rodbard","year":"2017","unstructured":"Rodbard D. Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes. Diabetes Technol Ther. 2017;19(S3):S-25-S\u221237. https:\/\/doi.org\/10.1089\/dia.2017.0035.","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"3285_CR43","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.2337\/dci18-0019","volume":"41","author":"WT Cefalu","year":"2018","unstructured":"Cefalu WT, Dawes DE, Gavlak G, Goldman D, Herman WH, Van Nuys K, et al. Insulin access and affordability working group: conclusions and recommendations. Diabetes Care. 2018;41(6):1299\u2013311. https:\/\/doi.org\/10.2337\/dci18-0019.","journal-title":"Diabetes Care"},{"issue":"3","key":"3285_CR44","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2337\/ds18-0091","volume":"32","author":"C Berget","year":"2019","unstructured":"Berget C, Messer LH, Forlenza GP. A clinical overview of insulin pump therapy for the management of diabetes: past, present and future of intensive therapy. Diabetes Spectr. 2019;32(3):194\u2013204. https:\/\/doi.org\/10.2337\/ds18-0091.","journal-title":"Diabetes Spectr"},{"issue":"2","key":"3285_CR45","doi-asserted-by":"publisher","first-page":"OE01","DOI":"10.7860\/jcdr\/2017\/23626.9732","volume":"11","author":"RR Mohanty","year":"2017","unstructured":"Mohanty RR. Inhaled insulin - current direction of insulin research. J Clin Diagn Res. 2017;11(2):OE01\u20134. https:\/\/doi.org\/10.7860\/jcdr\/2017\/23626.9732.","journal-title":"J Clin Diagn Res"},{"key":"3285_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.addr.2018.12.006","volume":"139","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Yu J, Kahkoska AR, Wang J, Buse JB, Gu Z. Advances in transdermal insulin delivery. Adv Drug Deliv Rev. 2019;139:51\u201370. https:\/\/doi.org\/10.1016\/j.addr.2018.12.006.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"3285_CR47","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrendo.2012.28","volume":"8","author":"JC Pickup","year":"2012","unstructured":"Pickup JC. Management of diabetes mellitus: is the pump mightier than the pen? Nat Rev Endocrinol. 2012;8(7):425\u201333. https:\/\/doi.org\/10.1038\/nrendo.2012.28.","journal-title":"Nat Rev Endocrinol"},{"issue":"9950","key":"3285_CR48","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/s0140-6736(14)61037-0","volume":"384","author":"Y Reznik","year":"2014","unstructured":"Reznik Y, Cohen O, Aronson R, Conget I, Runzis S, Castaneda J, et al. Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial. Lancet. 2014;384(9950):1265\u201372. https:\/\/doi.org\/10.1016\/s0140-6736(14)61037-0.","journal-title":"Lancet"},{"issue":"3","key":"3285_CR49","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1517\/17425247.2016.1115013","volume":"13","author":"H Thabit","year":"2016","unstructured":"Thabit H, Hovorka R. Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons. Expert Opin Drug Deliv. 2016;13(3):389\u2013400. https:\/\/doi.org\/10.1517\/17425247.2016.1115013.","journal-title":"Expert Opin Drug Deliv"},{"issue":"7","key":"3285_CR50","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nrd836","volume":"1","author":"DR Owens","year":"2002","unstructured":"Owens DR. New horizons\u2014alternative routes for insulin therapy. Nat Rev Drug Discov. 2002;1(7):529\u201340. https:\/\/doi.org\/10.1038\/nrd836.","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"3285_CR51","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2165\/00003088-200443120-00002","volume":"43","author":"JS Patton","year":"2004","unstructured":"Patton JS, Bukar JG, Eldon MA. Clinical pharmacokinetics and pharmacodynamics of inhaled insulin. Clin Pharmacokinet. 2004;43(12):781\u2013801. https:\/\/doi.org\/10.2165\/00003088-200443120-00002.","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"3285_CR52","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1021\/nn400630x","volume":"7","author":"Z Gu","year":"2013","unstructured":"Gu Z, Aimetti AA, Wang Q, Dang TT, Zhang Y, Veiseh O, et al. Injectable nano-network for glucose-mediated insulin delivery. ACS Nano. 2013;7(5):4194\u2013201. https:\/\/doi.org\/10.1021\/nn400630x.","journal-title":"ACS Nano"},{"issue":"11","key":"3285_CR53","doi-asserted-by":"publisher","first-page":"18223","DOI":"10.1021\/acsnano.2c05687","volume":"16","author":"Q Chen","year":"2022","unstructured":"Chen Q, Xiao Z, Wang C, Chen G, Zhang Y, Zhang X, et al. Microneedle patches loaded with nanovesicles for glucose transporter-mediated insulin delivery. ACS Nano. 2022;16(11):18223\u201331. https:\/\/doi.org\/10.1021\/acsnano.2c05687.","journal-title":"ACS Nano"},{"issue":"18","key":"3285_CR54","doi-asserted-by":"publisher","first-page":"20576","DOI":"10.1021\/acsami.1c24955","volume":"14","author":"B Lu","year":"2022","unstructured":"Lu B, GhavamiNejad A, Liu JF, Li J, Mirzaie S, Giacca A, et al. \u201cSmart\u201d composite microneedle patch stabilizes glucagon and prevents nocturnal hypoglycemia: experimental studies and molecular dynamics simulation. ACS Appl Mater Interfaces. 2022;14(18):20576\u201390. https:\/\/doi.org\/10.1021\/acsami.1c24955.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"12","key":"3285_CR55","doi-asserted-by":"publisher","first-page":"8640","DOI":"10.1021\/acsabm.0c01042","volume":"3","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li J, Wu M, Guo Z, Tan D, Zhou X, et al. Glucose-responsive gold nanocluster-loaded microneedle patch for type 1 diabetes therapy. ACS Appl Bio Mater. 2020;3(12):8640\u20139. https:\/\/doi.org\/10.1021\/acsabm.0c01042.","journal-title":"ACS Appl Bio Mater"},{"issue":"5","key":"3285_CR56","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41551-019-0508-y","volume":"4","author":"J Yu","year":"2020","unstructured":"Yu J, Wang J, Zhang Y, Chen G, Mao W, Ye Y, et al. Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs. Nat Biomed Eng. 2020;4(5):499\u2013506. https:\/\/doi.org\/10.1038\/s41551-019-0508-y.","journal-title":"Nat Biomed Eng"},{"issue":"16","key":"3285_CR57","doi-asserted-by":"publisher","first-page":"e2100827","DOI":"10.1002\/advs.202100827","volume":"8","author":"X Li","year":"2021","unstructured":"Li X, Huang X, Mo J, Wang H, Huang Q, Yang C, et al. A fully integrated closed-loop system based on mesoporous microneedles-iontophoresis for diabetes treatment. Adv Sci. 2021;8(16):e2100827. https:\/\/doi.org\/10.1002\/advs.202100827.","journal-title":"Adv Sci"},{"issue":"2","key":"3285_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.47672\/ejb.409","volume":"5","author":"Y Mukhtar","year":"2020","unstructured":"Mukhtar Y, Galalain A, Yunusa U. A modern overview on diabetes mellitus: a chronic endocrine disorder. Eur J Biol. 2020;5(2):1\u201314. https:\/\/doi.org\/10.47672\/ejb.409.","journal-title":"Eur J Biol"},{"issue":"1","key":"3285_CR59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.nut.2009.08.001","volume":"26","author":"RI Henkin","year":"2010","unstructured":"Henkin RI. Inhaled insulin\u2014intrapulmonary, intranasal and other routes of administration: mechanisms of action. Nutrition. 2010;26(1):33\u20139. https:\/\/doi.org\/10.1016\/j.nut.2009.08.001.","journal-title":"Nutrition"},{"issue":"6","key":"3285_CR60","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1185\/03007990902905724","volume":"25","author":"AZ Fu","year":"2009","unstructured":"Fu AZ, Qiu Y, Radican L. Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes. Curr Med Res Opin. 2009;25(6):1413\u201320. https:\/\/doi.org\/10.1185\/03007990902905724.","journal-title":"Curr Med Res Opin"},{"key":"3285_CR61","doi-asserted-by":"publisher","unstructured":"Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE). BMJ. 2017;356:j1285. https:\/\/doi.org\/10.1136\/bmj.j1285.","DOI":"10.1136\/bmj.j1285"},{"key":"3285_CR62","doi-asserted-by":"publisher","first-page":"923","DOI":"10.2147\/ppa.s87271","volume":"9","author":"Q Zhou","year":"2015","unstructured":"Zhou Q, Jin J, Zhu L, Chen M, Xu H, Wang H, et al. The optimal choice of medication administration route regarding intravenous, intramuscular and subcutaneous injection. Patient Prefer Adherence. 2015;9:923\u201342. https:\/\/doi.org\/10.2147\/ppa.s87271.","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"3285_CR63","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/dmrr.2653","volume":"32","author":"P Pozzilli","year":"2016","unstructured":"Pozzilli P, Battelino T, Danne T, Hovorka R, Jarosz-Chobot P, Renard E. Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy and pharmacoeconomics. Diabetes Metab Res Rev. 2016;32(1):21\u201339. https:\/\/doi.org\/10.1002\/dmrr.2653.","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"3285_CR64","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.drudis.2018.11.010","volume":"24","author":"N Easa","year":"2019","unstructured":"Easa N, Alany RG, Carew M, Vangala A. A review of non-invasive insulin delivery systems for diabetes therapy in clinical trials over the past decade. Drug Discov Today. 2019;24(2):440\u201351. https:\/\/doi.org\/10.1016\/j.drudis.2018.11.010.","journal-title":"Drug Discov Today"},{"issue":"6","key":"3285_CR65","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.3109\/10717544.2015.1058433","volume":"23","author":"C Liu","year":"2016","unstructured":"Liu C, Shan W, Liu M, Zhu X, Xu J, Xu Y, et al. A novel ligand conjugated nanoparticles for oral insulin delivery. Drug Deliv. 2016;23(6):2015\u201325. https:\/\/doi.org\/10.3109\/10717544.2015.1058433.","journal-title":"Drug Deliv"},{"issue":"3","key":"3285_CR66","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1177\/1932296820983863","volume":"16","author":"L Heinemann","year":"2021","unstructured":"Heinemann L, Schnell O, Gehr B, Schloot NC, G\u00f6rgens SW, G\u00f6rgen C. Digital diabetes management: a literature review of smart insulin pens. J Diabetes Sci Technol. 2021;16(3):587\u201395. https:\/\/doi.org\/10.1177\/1932296820983863.","journal-title":"J Diabetes Sci Technol"},{"key":"3285_CR67","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jconrel.2022.11.032","volume":"353","author":"H Wu","year":"2023","unstructured":"Wu H, Nan J, Yang L, Park HJ, Li J. Insulin-loaded liposomes packaged in alginate hydrogels promote the oral bioavailability of insulin. J Control Release. 2023;353:51\u201362. https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.032.","journal-title":"J Control Release"},{"issue":"2\u20133","key":"3285_CR68","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/s0169-409x(98)00073-8","volume":"35","author":"M Hinchcliffe","year":"1999","unstructured":"Hinchcliffe M, Illum L. Intranasal insulin delivery and therapy. Adv Drug Deliv Rev. 1999;35(2\u20133):199\u2013234. https:\/\/doi.org\/10.1016\/s0169-409x(98)00073-8.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"3285_CR69","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1039\/d0tb02133d","volume":"9","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wu M, Tan D, Liu Q, Xia R, Chen M, et al. A dissolving and glucose-responsive insulin-releasing microneedle patch for type 1 diabetes therapy. J Mater Chem B. 2021;9(3):648\u201357. https:\/\/doi.org\/10.1039\/d0tb02133d.","journal-title":"J Mater Chem B"},{"key":"3285_CR70","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.diabres.2017.11.018","volume":"136","author":"P Kesharwani","year":"2018","unstructured":"Kesharwani P, Gorain B, Low SY, Tan SA, Ling ECS, Lim YK, et al. Nanotechnology based approaches for anti-diabetic drugs delivery. Diabetes Res Clin Pract. 2018;136:52\u201377. https:\/\/doi.org\/10.1016\/j.diabres.2017.11.018.","journal-title":"Diabetes Res Clin Pract"},{"issue":"13","key":"3285_CR71","doi-asserted-by":"publisher","first-page":"e20070102","DOI":"10.1002\/adma.202070102","volume":"32","author":"J Wang","year":"2020","unstructured":"Wang J, Wang Z, Yu J, Kahkoska AR, Buse JB, Gu Z. Glucose\u2010responsive systems: glucose\u2010responsive insulin and delivery systems: innovation and translation (Adv. Mater. 13\/2020). Adv Mater. 2020;32(13):e20070102. https:\/\/doi.org\/10.1002\/adma.202070102.","journal-title":"Adv Mater"},{"issue":"4","key":"3285_CR72","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/jama.2016.19975","volume":"317","author":"RW Beck","year":"2017","unstructured":"Beck RW, Riddlesworth T, Ruedy K, Ahmann A, Bergenstal R, Haller S, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections. JAMA. 2017;317(4):371\u20138. https:\/\/doi.org\/10.1001\/jama.2016.19975.","journal-title":"JAMA"},{"issue":"S2","key":"3285_CR73","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1089\/dia.2015.0345","volume":"18","author":"J Kropff","year":"2016","unstructured":"Kropff J, DeVries JH. Continuous glucose monitoring, future products and update on worldwide artificial pancreas projects. Diabetes Technol Ther. 2016;18(S2):S2-53. https:\/\/doi.org\/10.1089\/dia.2015.0345.","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"3285_CR74","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrendo.2011.32","volume":"7","author":"R Hovorka","year":"2011","unstructured":"Hovorka R. Closed-loop insulin delivery: from bench to clinical practice. Nat Rev Endocrinol. 2011;7(7):385\u201395. https:\/\/doi.org\/10.1038\/nrendo.2011.32.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"3285_CR75","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11154-021-09635-3","volume":"22","author":"F Boscari","year":"2021","unstructured":"Boscari F, Avogaro A. Current treatment options and challenges in patients with type 1 diabetes: pharmacological, technical advances and future perspectives. Rev Endocr Metab Disord. 2021;22(2):217\u201340. https:\/\/doi.org\/10.1007\/s11154-021-09635-3.","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"3285_CR76","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2217\/dmt.15.43","volume":"5","author":"KK Hood","year":"2015","unstructured":"Hood KK, Hilliard M, Piatt G, Ievers-Landis CE. Effective strategies for encouraging behavior change in people with diabetes. Diabetes Manag (Lond). 2015;5(6):499\u2013510. https:\/\/doi.org\/10.2217\/dmt.15.43.","journal-title":"Diabetes Manag (Lond)"},{"issue":"6","key":"3285_CR77","doi-asserted-by":"publisher","first-page":"819","DOI":"10.4093\/dmj.2020.0088","volume":"44","author":"SY Rhee","year":"2020","unstructured":"Rhee SY, Kim C, Shin DW, Steinhubl SR. Present and future of digital health in diabetes and metabolic disease. Diabetes Metab J. 2020;44(6):819\u201327. https:\/\/doi.org\/10.4093\/dmj.2020.0088.","journal-title":"Diabetes Metab J"},{"issue":"4","key":"3285_CR78","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1056\/nejmoa1314474","volume":"371","author":"SJ Russell","year":"2014","unstructured":"Russell SJ, El-Khatib FH, Sinha M, Magyar KL, McKeon K, Goergen LG, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med. 2014;371(4):313\u201325. https:\/\/doi.org\/10.1056\/nejmoa1314474.","journal-title":"N Engl J Med"},{"issue":"8","key":"3285_CR79","doi-asserted-by":"publisher","first-page":"160","DOI":"10.7324\/japs.2021.110824","volume":"11","author":"OO Emmanuel","year":"2021","unstructured":"Emmanuel OO, Mfonobong FA, Koofreh GD, Musiliu OA. Advances in the science and technology of insulin delivery: a review. J Appl Pharm Sci. 2021;11(8):160\u20139. https:\/\/doi.org\/10.7324\/japs.2021.110824.","journal-title":"J Appl Pharm Sci"},{"issue":"3","key":"3285_CR80","doi-asserted-by":"publisher","first-page":"278","DOI":"10.4103\/0250-474x.42968","volume":"70","author":"M Al-Tabakha","year":"2008","unstructured":"Al-Tabakha M, Arida A. Recent challenges in insulin delivery systems: a review. Indian J Pharm Sci. 2008;70(3):278\u201384. https:\/\/doi.org\/10.4103\/0250-474x.42968.","journal-title":"Indian J Pharm Sci"},{"issue":"1","key":"3285_CR81","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/ijdt.ijdt2423","volume":"2","author":"J Kesavadev","year":"2023","unstructured":"Kesavadev J, Joshi S, Saboo B, Parikh R, Chawla M, Gupta A, et al. Advancements in insulin delivery technology: a journey of evolution. J Diabetes Sci Technol. 2023;2(1):7\u201319. https:\/\/doi.org\/10.4103\/ijdt.ijdt2423.","journal-title":"J Diabetes Sci Technol"},{"issue":"8","key":"3285_CR82","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.amjmed.2020.03.033","volume":"133","author":"S Ellahham","year":"2020","unstructured":"Ellahham S. Artificial intelligence: the future for diabetes care. Am J Med. 2020;133(8):895\u2013900. https:\/\/doi.org\/10.1016\/j.amjmed.2020.03.033.","journal-title":"Am J Med"},{"issue":"4","key":"3285_CR83","doi-asserted-by":"publisher","first-page":"248","DOI":"10.4258\/hir.2019.25.4.248","volume":"25","author":"S Abhari","year":"2019","unstructured":"Abhari S, Niakan Kalhori SR, Ebrahimi M, Hasannejadasl H, Garavand A. Artificial intelligence applications in type 2 diabetes mellitus care: focus on machine learning methods. Healthc Inform Res. 2019;25(4):248\u201361. https:\/\/doi.org\/10.4258\/hir.2019.25.4.248.","journal-title":"Healthc Inform Res"},{"issue":"8","key":"3285_CR84","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/pedi.13272","volume":"22","author":"E Giani","year":"2021","unstructured":"Giani E, Dovc K, Dos Santos TJ, Chobot A, Braune K, Cardona-Hernandez R, et al. Telemedicine and COVID-19 pandemic: the perfect storm to mark a change in diabetes care. Results from a world-wide cross-sectional web-based survey. Pediatr Diabetes. 2021;22(8):1115\u20139. https:\/\/doi.org\/10.1111\/pedi.13272.","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"3285_CR85","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jobcr.2021.11.010","volume":"12","author":"R Dwivedi","year":"2022","unstructured":"Dwivedi R, Mehrotra D, Chandra S. Potential of internet of medical things (IoMT) applications in building a smart healthcare system: a systematic review. J Oral Biol Craniofac Res. 2022;12(2):302\u201318. https:\/\/doi.org\/10.1016\/j.jobcr.2021.11.010.","journal-title":"J Oral Biol Craniofac Res"},{"key":"3285_CR86","doi-asserted-by":"publisher","DOI":"10.2196\/38592","volume":"8","author":"HNC Fu","year":"2023","unstructured":"Fu HNC, Wyman JF, Peden-McAlpine CJ, Draucker CB, Schleyer T, Adam TJ. App design features important for diabetes self-management as determined by the self-determination theory on motivation: content analysis of survey responses from adults requiring insulin therapy. JMIR Diabetes. 2023;8: e38592. https:\/\/doi.org\/10.2196\/38592.","journal-title":"JMIR Diabetes"},{"key":"3285_CR87","doi-asserted-by":"publisher","unstructured":"An effective model of diabetes care and education. revising the AADE7 self-care behaviors\u00ae. Diabetes Educ. 2020;46(2):139\u201360. https:\/\/doi.org\/10.1177\/0145721719894903.","DOI":"10.1177\/0145721719894903"},{"key":"3285_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.994766","volume":"10","author":"K Asmat","year":"2022","unstructured":"Asmat K, Dhamani K, Gul R, Froelicher ES. The effectiveness of patient-centered care vs. usual care in type 2 diabetes self-management: a systematic review and meta-analysis. Front Public Health. 2022;10: 994766. https:\/\/doi.org\/10.3389\/fpubh.2022.994766.","journal-title":"Front Public Health"},{"issue":"S2","key":"3285_CR89","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1089\/dia.2018.0115","volume":"20","author":"TS Bailey","year":"2018","unstructured":"Bailey TS, Walsh J, Stone JY. Emerging technologies for diabetes care. Diabetes Technol Ther. 2018;20(S2):S2-78. https:\/\/doi.org\/10.1089\/dia.2018.0115.","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"3285_CR90","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11606-006-0242-5","volume":"21","author":"CL Jackson","year":"2006","unstructured":"Jackson CL, Bolen S, Brancati FL, Batts-Turner ML, Gary TL. A systematic review of interactive computer-assisted technology in diabetes care. J Gen Intern Med. 2006;21(2):105\u201310. https:\/\/doi.org\/10.1007\/s11606-006-0242-5.","journal-title":"J Gen Intern Med"},{"issue":"11","key":"3285_CR91","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1089\/dia.2019.0449","volume":"22","author":"RZ Jafri","year":"2020","unstructured":"Jafri RZ, Balliro CA, El-Khatib F, Maheno MM, Hillard MA, O\u2019Donovan A, et al. A three-way accuracy comparison of the Dexcom G5, Abbott FreeStyle Libre Pro and Senseonics Eversense continuous glucose monitoring devices in a home-use study of subjects with type 1 diabetes. Diabetes Technol Ther. 2020;22(11):846\u201352. https:\/\/doi.org\/10.1089\/dia.2019.0449.","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"3285_CR92","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1089\/dia.2022.0153","volume":"24","author":"K Dovc","year":"2022","unstructured":"Dovc K, Battelino T, Beck RW, Sibayan J, Bailey RJ, Calhoun P, et al. Impact of temporary glycemic target use in the hybrid and advanced hybrid closed-loop systems. Diabetes Technol Ther. 2022;24(11):848\u201352. https:\/\/doi.org\/10.1089\/dia.2022.0153.","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"3285_CR93","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s42234-018-0015-6","volume":"4","author":"B Kovatchev","year":"2018","unstructured":"Kovatchev B. Automated closed-loop control of diabetes: the artificial pancreas. Bioelectron Med. 2018;4(1):15. https:\/\/doi.org\/10.1186\/s42234-018-0015-6.","journal-title":"Bioelectron Med"},{"issue":"6","key":"3285_CR94","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1089\/dia.2007.0284","volume":"10","author":"H Zisser","year":"2008","unstructured":"Zisser H, Robinson L, Bevier W, Dassau E, Ellingsen C, Doyle FJ, et al. Bolus calculator: a review of four \u201csmart\u201d insulin pumps. Diabetes Technol Ther. 2008;10(6):441\u20134. https:\/\/doi.org\/10.1089\/dia.2007.0284.","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"3285_CR95","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2174\/1872210513666190104122032","volume":"13","author":"R Siwach","year":"2019","unstructured":"Siwach R, Pandey P, Chawla V, Dureja H. Role of nanotechnology in diabetic management. Recent Pat Nanotechnol. 2019;13(1):28\u201337. https:\/\/doi.org\/10.2174\/1872210513666190104122032.","journal-title":"Recent Pat Nanotechnol"},{"issue":"7","key":"3285_CR96","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11892-018-1015-3","volume":"18","author":"ME McDonnell","year":"2018","unstructured":"McDonnell ME. Telemedicine in complex diabetes management. Curr Diabetes Rep. 2018;18(7):42. https:\/\/doi.org\/10.1007\/s11892-018-1015-3.","journal-title":"Curr Diabetes Rep"},{"issue":"12","key":"3285_CR97","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11892-021-01423-2","volume":"21","author":"A Nomura","year":"2021","unstructured":"Nomura A, Noguchi M, Kometani M, Furukawa K, Yoneda T. Artificial intelligence in current diabetes management and prediction. Curr Diabetes Rep. 2021;21(12):57. https:\/\/doi.org\/10.1007\/s11892-021-01423-2.","journal-title":"Curr Diabetes Rep"},{"issue":"10057","key":"3285_CR98","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/s0140-6736(16)31535-5","volume":"388","author":"J Bolinder","year":"2016","unstructured":"Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kr\u00f6ger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388(10057):2254\u201363. https:\/\/doi.org\/10.1016\/s0140-6736(16)31535-5.","journal-title":"Lancet"},{"issue":"9","key":"3285_CR99","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s00125-016-4022-4","volume":"59","author":"H Thabit","year":"2016","unstructured":"Thabit H, Hovorka R. Coming of age: the artificial pancreas for type 1 diabetes. Diabetologia. 2016;59(9):1795\u2013805. https:\/\/doi.org\/10.1007\/s00125-016-4022-4.","journal-title":"Diabetologia"},{"issue":"27","key":"3285_CR100","doi-asserted-by":"publisher","first-page":"8260","DOI":"10.1073\/pnas.1505405112","volume":"112","author":"J Yu","year":"2015","unstructured":"Yu J, Zhang Y, Ye Y, DiSanto R, Sun W, Ranson D, et al. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery. Proc Natl Acad Sci U S A. 2015;112(27):8260\u20135. https:\/\/doi.org\/10.1073\/pnas.1505405112.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"3285_CR101","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11892-015-0644-z","volume":"15","author":"M Joshi","year":"2015","unstructured":"Joshi M, Choudhary P. Multiple daily injections or insulin pump therapy: choosing the best option for your patient\u2014an evidence-based approach. Curr Diabetes Rep. 2015;15(10):88. https:\/\/doi.org\/10.1007\/s11892-015-0644-z.","journal-title":"Curr Diabetes Rep"},{"issue":"1","key":"3285_CR102","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/(SICI)1096-9136(199701)14:1<63::AID-DIA298>3.0.CO;2-F","volume":"14","author":"L Heinemann","year":"1997","unstructured":"Heinemann L, Traut T, Heise T. Time-action profile of inhaled insulin. Diabet Med. 1997;14(1):63\u201372.","journal-title":"Diabet Med"},{"key":"3285_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.00880","volume":"8","author":"R Zhao","year":"2020","unstructured":"Zhao R, Lu Z, Yang J, Zhang L, Li Y, Zhang X. Drug delivery system in the treatment of diabetes mellitus. Front Bioeng Biotechnol. 2020;8: 880. https:\/\/doi.org\/10.3389\/fbioe.2020.00880.","journal-title":"Front Bioeng Biotechnol"},{"issue":"2","key":"3285_CR104","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1089\/dia.2018.0384","volume":"21","author":"NC Foster","year":"2019","unstructured":"Foster NC, Beck RW, Miller KM, Clements MA, Rickels MR, DiMeglio LA, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016\u20132018. Diabetes Technol Ther. 2019;21(2):66\u201372. https:\/\/doi.org\/10.1089\/dia.2018.0384.","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"3285_CR105","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1399-543x.2006.00145.x","volume":"7","author":"R Hanas","year":"2006","unstructured":"Hanas R, Adolfsson P. Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia. Pediatr Diabetes. 2006;7(1):25\u201331. https:\/\/doi.org\/10.1111\/j.1399-543x.2006.00145.x.","journal-title":"Pediatr Diabetes"},{"issue":"10","key":"3285_CR106","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.2337\/diacare.27.10.2356","volume":"27","author":"PA Hollander","year":"2004","unstructured":"Hollander PA, Blonde L, Rowe R, Mehta AE, Milburn JL, Hershon KS, et al. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes. Diabetes Care. 2004;27(10):2356\u201362. https:\/\/doi.org\/10.2337\/diacare.27.10.2356.","journal-title":"Diabetes Care"},{"issue":"38","key":"3285_CR107","doi-asserted-by":"publisher","first-page":"e7939","DOI":"10.1097\/md.0000000000007939","volume":"96","author":"H Liang","year":"2017","unstructured":"Liang H, Ma S, Xiao Y, Tan H. Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus. Medicine (Baltimore). 2017;96(38):e7939. https:\/\/doi.org\/10.1097\/md.0000000000007939.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"3285_CR108","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/1932296820984490","volume":"16","author":"T Kompala","year":"2021","unstructured":"Kompala T, Neinstein AB. Smart insulin pens: advancing digital transformation and a connected diabetes care ecosystem. J Diabetes Sci Technol. 2021;16(3):596\u2013604. https:\/\/doi.org\/10.1177\/1932296820984490.","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"3285_CR109","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s13300-020-00980-1","volume":"12","author":"J Jendle","year":"2020","unstructured":"Jendle J, Ericsson \u00c5, Gundgaard J, M\u00f8ller JB, Valentine WJ, Hunt B. Smart insulin pens are associated with improved clinical outcomes at lower cost versus standard-of-care treatment of type 1 diabetes in Sweden: a cost-effectiveness analysis. Diabetes Ther. 2020;12(1):373\u201388. https:\/\/doi.org\/10.1007\/s13300-020-00980-1.","journal-title":"Diabetes Ther"},{"key":"3285_CR110","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.addr.2020.06.016","volume":"154\u2013155","author":"M Hasan","year":"2020","unstructured":"Hasan M, Khatun A, Fukuta T, Kogure K. Noninvasive transdermal delivery of liposomes by weak electric current. Adv Drug Deliv Rev. 2020;154\u2013155:227\u201335. https:\/\/doi.org\/10.1016\/j.addr.2020.06.016.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"3285_CR111","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1210\/jc.2011-1802","volume":"97","author":"E Shemesh","year":"2012","unstructured":"Shemesh E, Rudich A, Harman-Boehm I, Cukierman-Yaffe T. Effect of intranasal insulin on cognitive function: a systematic review. J Clin Endocrinol Metab. 2012;97(2):366\u201376. https:\/\/doi.org\/10.1210\/jc.2011-1802.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"3285_CR112","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s11095-007-9256-x","volume":"24","author":"L Nordquist","year":"2007","unstructured":"Nordquist L, Roxhed N, Griss P, Stemme G. Novel microneedle patches for active insulin delivery are efficient in maintaining glycaemic control: an initial comparison with subcutaneous administration. Pharm Res. 2007;24(7):1381\u20138. https:\/\/doi.org\/10.1007\/s11095-007-9256-x.","journal-title":"Pharm Res"},{"key":"3285_CR113","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jconrel.2017.01.043","volume":"263","author":"J Yang","year":"2017","unstructured":"Yang J, Cao Z. Glucose-responsive insulin release: analysis of mechanisms, formulations and evaluation criteria. J Control Release. 2017;263:231\u20139. https:\/\/doi.org\/10.1016\/j.jconrel.2017.01.043.","journal-title":"J Control Release"},{"issue":"9","key":"3285_CR114","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1016\/j.xphs.2019.04.022","volume":"108","author":"A Abramson","year":"2019","unstructured":"Abramson A, Halperin F, Kim J, Traverso G. Quantifying the value of orally delivered biologic therapies: a cost-effectiveness analysis of oral semaglutide. J Pharm Sci. 2019;108(9):3138\u201345. https:\/\/doi.org\/10.1016\/j.xphs.2019.04.022.","journal-title":"J Pharm Sci"},{"issue":"13","key":"3285_CR115","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jama.2021.13478","volume":"326","author":"TW Martens","year":"2021","unstructured":"Martens TW, Beck RW, Bergenstal RM. Continuous glucose monitoring and glycemic control in patients with type 2 diabetes treated with basal insulin\u2014reply. JAMA. 2021;326(13):1330. https:\/\/doi.org\/10.1001\/jama.2021.13478.","journal-title":"JAMA"},{"issue":"7","key":"3285_CR116","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2337\/dc15-2716","volume":"39","author":"DM Maahs","year":"2016","unstructured":"Maahs DM, Buckingham BA, Castle JR, Cinar A, Damiano ER, Dassau E, et al. Outcome measures for artificial pancreas clinical trials: a consensus report. Diabetes Care. 2016;39(7):1175\u20139. https:\/\/doi.org\/10.2337\/dc15-2716.","journal-title":"Diabetes Care"},{"issue":"2","key":"3285_CR117","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1213\/ane.0000000000001372","volume":"124","author":"E Brogi","year":"2017","unstructured":"Brogi E, Cyr S, Kazan R, Giunta F, Hemmerling TM. Clinical performance and safety of closed-loop systems: a systematic review and meta-analysis of randomized controlled trials. Anesth Analg. 2017;124(2):446\u201355. https:\/\/doi.org\/10.1213\/ane.0000000000001372.","journal-title":"Anesth Analg"},{"issue":"1\u20132","key":"3285_CR118","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1504\/ijnt.2011.037170","volume":"8","author":"D Samuel","year":"2011","unstructured":"Samuel D, Bharali D, Mousa SA. The role of nanotechnology in diabetes treatment: current and future perspectives. Int J Nanotechnol. 2011;8(1\u20132):53\u201365. https:\/\/doi.org\/10.1504\/ijnt.2011.037170.","journal-title":"Int J Nanotechnol"},{"issue":"1","key":"3285_CR119","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1517\/17425247.5.1.45","volume":"5","author":"C Damg\u00e9","year":"2008","unstructured":"Damg\u00e9 C, Reis CP, Maincent P. Nanoparticle strategies for the oral delivery of insulin. Expert Opin Drug Deliv. 2008;5(1):45\u201368. https:\/\/doi.org\/10.1517\/17425247.5.1.45.","journal-title":"Expert Opin Drug Deliv"},{"issue":"9","key":"3285_CR120","doi-asserted-by":"publisher","first-page":"E341","DOI":"10.1503\/cmaj.150885","volume":"189","author":"LI Faruque","year":"2017","unstructured":"Faruque LI, Wiebe N, Ehteshami-Afshar A, Liu Y, Dianati-Maleki N, Hemmelgarn BR, et al. Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials. CMAJ. 2017;189(9):E341\u201364. https:\/\/doi.org\/10.1503\/cmaj.150885.","journal-title":"CMAJ"},{"issue":"1","key":"3285_CR121","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ajps.2020.01.001","volume":"15","author":"LC Ng","year":"2020","unstructured":"Ng LC, Gupta M. Transdermal drug delivery systems in diabetes management: a review. Asian J Pharm Sci. 2020;15(1):13\u201325. https:\/\/doi.org\/10.1016\/j.ajps.2020.01.001.","journal-title":"Asian J Pharm Sci"},{"issue":"1","key":"3285_CR122","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s41745-023-00205-8","volume":"103","author":"AM Almurashi","year":"2023","unstructured":"Almurashi AM, Rodriguez E, Garg SK. Emerging diabetes technologies: continuous glucose monitors\/artificial pancreases. J Indian Inst Sci. 2023;103(1):205\u201330. https:\/\/doi.org\/10.1007\/s41745-023-00205-8.","journal-title":"J Indian Inst Sci"},{"issue":"1","key":"3285_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4093\/dmj.2023.0011","volume":"47","author":"JH Yoo","year":"2023","unstructured":"Yoo JH, Kim JH. Advances in continuous glucose monitoring and integrated devices for management of diabetes with insulin-based therapy: improvement in glycemic control. Diabetes Metab J. 2023;47(1):1\u201313. https:\/\/doi.org\/10.4093\/dmj.2023.0011.","journal-title":"Diabetes Metab J"},{"issue":"10","key":"3285_CR124","doi-asserted-by":"publisher","first-page":"101628","DOI":"10.1016\/j.xcrm.2023.101628","volume":"4","author":"Z Guan","year":"2023","unstructured":"Guan Z, Li H, Liu R, Cai C, Liu Y, Li J, et al. Artificial intelligence in diabetes management: advancements, opportunities and challenges. Cell Rep Med. 2023;4(10):101628. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101628.","journal-title":"Cell Rep Med"},{"key":"3285_CR125","doi-asserted-by":"publisher","unstructured":"Brantly ND. Automating health: the promises and perils of biomedical technologies for diabetes management. VT Electron Thesis and Dissertation. 2023. https:\/\/doi.org\/10.1109\/5.771073.","DOI":"10.1109\/5.771073"},{"issue":"15","key":"3285_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/app14156565","volume":"14","author":"GN Pop","year":"2024","unstructured":"Pop GN, Manole F, Buleu F, Motofelea AC, Bircea S, Popa D, et al. Bridging the gap: a literature review of advancements in obesity and diabetes mellitus management. Appl Sci. 2024;14(15): 6565. https:\/\/doi.org\/10.3390\/app14156565.","journal-title":"Appl Sci"},{"issue":"15","key":"3285_CR127","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.2174\/1389450118666170923151144","volume":"19","author":"M Pandey","year":"2018","unstructured":"Pandey M, Choudhury H, Yi CX, Mun CW, Phing GK, Rou GX, et al. Recent updates on novel approaches in insulin drug delivery: a review of challenges and pharmaceutical implications. Curr Drug Targets. 2018;19(15):1782\u2013800. https:\/\/doi.org\/10.2174\/1389450118666170923151144.","journal-title":"Curr Drug Targets"},{"issue":"4","key":"3285_CR128","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1615\/JEnvironPatholToxicolOncol.2017032040","volume":"36","author":"DK Chellappan","year":"2017","unstructured":"Chellappan DK, Yenese Y, Wei CC, Chellian J, Gupta G. Oral insulin: current status, challenges and future perspectives. J Environ Pathol Toxicol Oncol. 2017;36(4):295\u2013305. https:\/\/doi.org\/10.1615\/JEnvironPatholToxicolOncol.2017032040.","journal-title":"J Environ Pathol Toxicol Oncol"},{"issue":"1\u20132","key":"3285_CR129","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijpharm.2018.03.028","volume":"542","author":"E Czuba","year":"2018","unstructured":"Czuba E, Diop M, Mura C, Schaschkow A, Langlois A, Bietiger W, et al. Oral insulin delivery, the challenge to increase insulin bioavailability: influence of surface charge in nanoparticle system. Int J Pharm. 2018;542(1\u20132):47\u201355. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.03.028.","journal-title":"Int J Pharm"},{"issue":"9","key":"3285_CR130","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/jphp.12621","volume":"68","author":"CY Wong","year":"2016","unstructured":"Wong CY, Martinez J, Dass CR. Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities. J Pharm Pharmacol. 2016;68(9):1093\u2013108. https:\/\/doi.org\/10.1111\/jphp.12621.","journal-title":"J Pharm Pharmacol"},{"key":"3285_CR131","doi-asserted-by":"publisher","first-page":"124399","DOI":"10.1016\/j.ijpharm.2023.124399","volume":"661","author":"R Kamelnia","year":"2024","unstructured":"Kamelnia R, Ahmadi-Hamedani M, Darrudi M, Kamelnia E. Improving the stability of insulin through effective chemical modifications: a comprehensive review. Int J Pharm. 2024;661:124399. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.124399.","journal-title":"Int J Pharm"},{"issue":"6","key":"3285_CR132","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2337\/dc17-1821","volume":"41","author":"W Wan","year":"2018","unstructured":"Wan W, Skandari MR, Minc A, Nathan AG, Winn A, Zarei P, et al. Cost-effectiveness of continuous glucose monitoring for adults with type 1 diabetes compared with self-monitoring of blood glucose: the DIAMOND randomized trial. Diabetes Care. 2018;41(6):1227\u201334. https:\/\/doi.org\/10.2337\/dc17-1821.","journal-title":"Diabetes Care"},{"issue":"1","key":"3285_CR133","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/s2213-8587(17)30186-9","volume":"6","author":"N Lascar","year":"2018","unstructured":"Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018;6(1):69\u201380. https:\/\/doi.org\/10.1016\/s2213-8587(17)30186-9.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3285_CR134","doi-asserted-by":"publisher","unstructured":"Addendum. 7. Diabetes technology: standards of medical care in diabetes\u20142020. Diabetes Care. 2020;43(8):1981\u20131981. https:\/\/doi.org\/10.2337\/dc20-ad08c.","DOI":"10.2337\/dc20-ad08c"},{"key":"3285_CR135","doi-asserted-by":"publisher","unstructured":"Kumar KA, Bose PS, Sathyanarayana MB, Vasantharaju SG, Ligade V, Amatha S, Osmani RA, Barwa R, Pawar SD, Ravi G. Strategic approaches for selecting regulatory pathways in drug-device combination products: A comprehensive review. J Appl Pharm Sci. 2025;15(7). https:\/\/doi.org\/10.7324\/JAPS.2025.244706.","DOI":"10.7324\/JAPS.2025.244706"},{"issue":"6","key":"3285_CR136","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S2213-8587(17)30100-6","volume":"5","author":"P Zhang","year":"2017","unstructured":"Zhang P, Gregg E. Global economic burden of diabetes and its implications. Lancet Diabetes Endocrinol. 2017;5(6):404\u20135. https:\/\/doi.org\/10.1016\/S2213-8587(17)30100-6.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3285_CR137","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.diabres.2018.01.023","volume":"138","author":"R Aronson","year":"2018","unstructured":"Aronson R, Galstyan G, Goldfracht M, Al Sifri S, Elliott L, Khunti K. Direct and indirect health economic impact of hypoglycaemia in a global population of patients with insulin-treated diabetes. Diabetes Res Clin Pract. 2018;138:35\u201343. https:\/\/doi.org\/10.1016\/j.diabres.2018.01.023.","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"3285_CR138","doi-asserted-by":"publisher","first-page":"134","DOI":"10.13107\/jmeta.2023.0008","volume":"11","author":"A Sanyaolu","year":"2023","unstructured":"Sanyaolu A, Marinkovic A, Prakash S, Williams M, Dixon Y, Okorie C, et al. Diabetes mellitus: an overview of the types, prevalence, comorbidity, complication, genetics, economic implicationand treatment. World J Meta-Anal. 2023;11(5):134\u201343. https:\/\/doi.org\/10.13107\/jmeta.2023.0008.","journal-title":"World J Meta-Anal"},{"issue":"3","key":"3285_CR139","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12876-023-02977-5","volume":"3","author":"L Hiremath","year":"2024","unstructured":"Hiremath L, Tripathi Y, Shetty S, Priyadarshini J, Pramod KB. Understanding insulin mechanisms, economic implications and future prospects. Asian Biomed J Appl Res. 2024;3(3):25\u201332. https:\/\/doi.org\/10.1186\/s12876-023-02977-5.","journal-title":"Asian Biomed J Appl Res"},{"issue":"11","key":"3285_CR140","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079246","volume":"8","author":"MS Marcolino","year":"2013","unstructured":"Marcolino MS, Maia JX, Alkmim MBM, Boersma E, Ribeiro AL. Telemedicine application in the care of diabetes patients: systematic review and meta-analysis. PLoS ONE. 2013;8(11): e79246. https:\/\/doi.org\/10.1371\/journal.pone.0079246.","journal-title":"PLoS ONE"},{"issue":"8","key":"3285_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/bios12080562","volume":"12","author":"P Manickam","year":"2022","unstructured":"Manickam P, Mariappan SA, Murugesan SM, Hansda S, Kaushik A, Shinde R, et al. Artificial intelligence (AI) and internet of medical things (IoMT) assisted biomedical systems for intelligent healthcare. Biosensors. 2022;12(8): 562. https:\/\/doi.org\/10.3390\/bios12080562.","journal-title":"Biosensors"},{"issue":"2","key":"3285_CR142","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ajhg.2023.01.001","volume":"110","author":"KA Broadaway","year":"2023","unstructured":"Broadaway KA, Yin X, Williamson A, Parsons VA, Wilson EP, Moxley AH, et al. Loci for insulin processing and secretion provide insight into type 2 diabetes risk. Am J Hum Genet. 2023;110(2):284\u201399. https:\/\/doi.org\/10.1016\/j.ajhg.2023.01.001.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"3285_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5493\/WJEM.V14.I1.1","volume":"14","author":"C Milionis","year":"2024","unstructured":"Milionis C, Ilias I, Lekkou A, Venaki E, Koukkou E. Future clinical prospects of C-peptide testing in the early diagnosis of gestational diabetes. World J Exp Med. 2024;14(1):1\u201310. https:\/\/doi.org\/10.5493\/WJEM.V14.I1.1.","journal-title":"World J Exp Med"},{"key":"3285_CR144","doi-asserted-by":"publisher","first-page":"2400048","DOI":"10.3390\/s2400048","volume":"2024","author":"TS Yu","year":"2024","unstructured":"Yu TS, Song S, Yea J, Jang KI. Diabetes management in transition: market insights and technological advancements in CGM and insulin delivery. J Sens. 2024;2024:2400048. https:\/\/doi.org\/10.3390\/s2400048.","journal-title":"J Sens"},{"issue":"8","key":"3285_CR145","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/jdi.1","volume":"14","author":"YK Yeh","year":"2023","unstructured":"Yeh YK, Yen FS, Hwu CM. Diet and exercise are a fundamental part of comprehensive care for type 2 diabetes. J Diabetes Investig. 2023;14(8):936\u201345. https:\/\/doi.org\/10.1111\/jdi.1.","journal-title":"J Diabetes Investig"},{"key":"3285_CR146","doi-asserted-by":"publisher","unstructured":"Yasmeen, Mamatha T, Zubair M, Begum S, Muneera T. Various emerging trends in insulin drug delivery systems. Br J Pharm Res. 2015;5(5):294\u2013308. https:\/\/doi.org\/10.9734\/bjpr\/2015\/12528.","DOI":"10.9734\/bjpr\/2015\/12528"},{"issue":"17","key":"3285_CR147","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20174230","volume":"20","author":"RJ Mehta","year":"2019","unstructured":"Mehta RJ, Gastaldelli A, Balas B, Ricotti A, DeFronzo RA, Tripathy D. Mechanism of action of inhaled insulin on whole body glucose metabolism in subjects with type 2 diabetes mellitus. Int J Mol Sci. 2019;20(17): 4230. https:\/\/doi.org\/10.3390\/ijms20174230.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3285_CR148","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/dme.13942","volume":"37","author":"P Avari","year":"2019","unstructured":"Avari P, Reddy M, Oliver N. Is it possible to constantly and accurately monitor blood sugar levels, in people with type 1 diabetes, with a discrete device (non-invasive or invasive)? Diabet Med. 2019;37(4):532\u201344. https:\/\/doi.org\/10.1111\/dme.13942.","journal-title":"Diabet Med"},{"issue":"484","key":"3285_CR149","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw4949","volume":"11","author":"CK Boughton","year":"2019","unstructured":"Boughton CK, Hovorka R. Advances in artificial pancreas systems. Sci Transl Med. 2019;11(484): eaaw4949. https:\/\/doi.org\/10.1126\/scitranslmed.aaw4949.","journal-title":"Sci Transl Med"},{"key":"3285_CR150","doi-asserted-by":"publisher","first-page":"636959","DOI":"10.3389\/fendo.2021.636959","volume":"12","author":"M Kamusheva","year":"2021","unstructured":"Kamusheva M, Tachkov K, Dimitrova M, Mitkova Z, Garc\u00eda-S\u00e1ez G, Hernando ME, et al. A systematic review of collective evidences investigating the effect of diabetes monitoring systems and their application in health care. Front Endocrinol (Lausanne). 2021;12:636959. https:\/\/doi.org\/10.3389\/fendo.2021.636959.","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03285-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03285-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03285-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T18:04:00Z","timestamp":1770314640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03285-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":150,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3285"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03285-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no conflict of interest, financial or otherwise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}],"article-number":"51"}}